Protective effects of setarud (IMOD™) on development of diet-induced hypercholesterolemia in rabbits

Daru

Volumn 16, Issue 4, 2008, Pages 218-222

  Azonov, J A ^a   Khorram Khorshid, H R ^b,c   Novitsky, Y A ^d   Farhadi, M ^e   Ghorbanoghli, Z ^f   Shahhosseiny, M H ^g  

^a Governmental Nutritional Research and Scientific Institute   (Tajikistan)

^b UNIVERSITY OF SOCIAL WELFARE AND REHABILITATION SCIENCES   (Iran)

^c AVICENNA RESEARCH INSTITUTE   (Iran)

^d Pars Roos Co   (Iran)

^e IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Hypercholesterolemia; IMOD ; Setarud

Indexed keywords

ALBUMIN; AMINOTRANSFERASE; BILIRUBIN; CHOLESTEROL; HERBACEOUS AGENT; HYPOCHOLESTEROLEMIC AGENT; IMOD; LIPID; SETARUD; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ALBUMIN BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; ATHEROGENESIS; BILIRUBIN BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIETARY INTAKE; DISEASE COURSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; GLUCOSE BLOOD LEVEL; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; LIVER FUNCTION; MALE; NONHUMAN; RABBIT; RISK REDUCTION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 58449128579     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Baker SK, Tarnopolsky MA. Statin myopathies: pathophysiologic and clinical perspectives. Clin Invest Med 2001; 24: 258-272.
2. Whanger PD. Selenocompounds in plants and animals and their biological significance. J Amer Coll Nutr, 2002; 21: 223-232.
3. Alissa EM, Bahijri SM, Gordon AF. The controversy surrounding selenium and cardiovascular disease: a review of the evidence. Med Sci Monit 2003; 9: RA9-18.
4. Thomson CD. Assessment of requirements for selenium and adequacy of selenium status: a review. Eur J Clin Nutr 2004; 58: 391-402.
5. Masukawa T, Goto J, Iwata H. Impaired metabolism of arachidonate in selenium deficient animals. Experientia 1983; 39: 405-406.
6. Hoffman DJ, Heinz GH, Krynitsky AJ. Hepatic glutathione metabolism and lipid peroxidation in response to excess dietary selenomethionine and selenite in mallard ducklings. J Toxicol Environ Health 1989; 27: 263-271.
7. LeBoeuf RA, Zentner KL, Hoekstra WG. Effects of dietary selenium concentration and duration of selenium feeding on hepatic glutathione concentrations in rats. Proc Soc Exp Biol Med 1985; 180: 348-352.
8. Vinson JA, Stella JM, Flanagan TJ. Selenium yeast is an effective in vitro and in vivo antioxidant and hypolipemic agent in normal hamsters. Nutr Res 1998; 18: 735-742.
9. Wójcicki J, Rózewicka L, Barcew-Wiszniewska B, Samochowiec L, Juźwiak S, Kadłubowska D. Effect of selenium and vitamin E on the development of experimental atherosclerosis in rabbits. Atherosclerosis 1991; 87: 9-16.
10. Liu W, Boylan LM. Alterations in plasma total and high density lipoprotein cholesterol levels in hyperlipidemic rats fed diets with varied content of selenium and vitamin E. Biol Trace Elem Res 1994; 42: 9-16.
11. Shaish A, Daugherty A, O'Sullivan F, Schonfeld G, Heinecke JW. Beta-carotene inhibits atherosclerosis in hypercholesterolemic rabbits. J Clin Invest 1995; 96: 2075-2082.
12. Juźwiak S, Wójcicki J, Mokrzycki K, Marchlewicz M, Białecka M, Wenda-Rózewicka L. Effect of quercetin on experimental hyperlipidemia and atherosclerosis in rabbits. Pharmacol Rep 2005; 57: 604-609.
13. Hume CW (Ed): The UFAW Handbook on the Care and Management of Laboratory Animals. Churchill Livigstone: Edinburgh/London. 1972.
14. Kritchevsky D. Experimental atherosclerosis in primates and other species. Annals of the New York Academy of Sciences 1969; 162: 80-88.
15. Djujic IS, Jozanov-Stankov ON, Milovac M, Jankovic V, Djermanovic V. Bioavailability and possible benefits of wheat intake naturally enriched with selenium and its products. Biol Trace Elem Res 2000; 77: 273-285.
16. Crespo AM, Lanca MJ, Vasconcelos S, Andrade V, Rodrigues H, Santos MC. Effect of selenium supplementation on some blood biochemical parameters in male rats. Biol Trace Elem Res 1995; 47:343-347.
17. Gonca S, Ceylan S, Yardimoulu M, Dalcik H, Kokturk S, Filiz S. Histopathological effects of cholesterol and protective effects of vitamin E and selenium on the morphology of liver. Turk J Med Sci 2000; 30: 551-555.
18. Ozdil S, Bolkent S, Yanardag R, Arda-Pirincci P. Protective effects of ascorbic acid, dl-alphatocopherol acetate, and sodium selenate on ethanol-induced liver damage of rats. Biol Trace Elem Res 2004; 97: 149-162.
19. Nassir F, Moundras C, Bayle D, Sérougne C, Gueux E, Rock E. Effect of selenium deficiency on hepatic lipid and lipoprotein metabolism in the rat. Br J Nutr 1997; 78: 493-500.
20. Poirier J, Cockell K, Hidiroglou N, Madere R, Trick K, Kubow S. The effects of vitamin E and selenium intake on oxidative stress and plasma lipids in hamsters fed fish oil. Lipids 2002; 37: 1125-1133.
21. Ness GC, Zhao Z. Thyroid hormone rapidly induces hepatic LDL receptor mRNA levels in hypophysectomized rats. Arch Biochem Biophys 1994; 315: 199-202.
22. Dhingra S, Bansal MP. Hypercholesterolemia and apolipoprotein B expression: Regulation by selenium status. Lipids Health Dis 2005; 4: 28.
23. Novitsky YA, Madani H, Gharibdoust F, Farhadi M, Farzamfar B, Mohraz M. 2007 EU Patent Application 087825.
24. Sun J, Giraud DW, Moxley RA, Driskell JA. beta-Carotene and alpha-tocopherol inhibit the development of atherosclerotic lesions in hypercholesterolemic rabbits. Int J Vitam Nutr Res 1997; 67: 155-163.